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A novel mass spectrometry-based methodology using electrospray ionization (ES11 is de- 
scribed for the detection of protein-protein [interferon (IFN>--Y dimer] and protein-&and 
[ vas-guanosine diphosphate (GDP)] noncovalent interactions. The method utilizes ES1 from 
aqueous solution at appropriate pH. The presence of the noncovalent complex of the IFN-y 
dimer was confirmed by the observed average molecular weight of 33,819 Da. The key to the 
detection of the IFN-y dimer is the use of an alkaline solution (pH -9) for sample 
preparation and for mass spectrornetry analysis. The effect of the declustering energy in the 
region of the ion sampling orifice and focusing quadrupole on the preservation of the 
gas-phase noncovalent complex (IFN-y dimer) was also studied. The effect of the decluster- 
ing energy on complex dissociation was further extended to probe the noncovalent 
protein-ligand association of rus-GDP. It was found that little energy is required to 
dissociate the IFN-y dimer, whereas a substantial amount of energy is required to dissociate 
the gas-phase ras_GDP complex. (1 Am Sot Mass Spectrom 1993, 4, 624-630) 
S 
ome of the most significant advances in mass 
spectrometry technology in recent years have been 
in the development and application of new ion- 
ization techniques. Application of mass spectrometry 
to the characterization of compounds with molecular 
weights greater than 1000 Da was rare prior to the 
development of desorption ionization methods. These 
developments include field desorption [l], fast-atom 
bombardment [Z, 31, and plasma desorption [4-71. 
More recently, matrix-assisted laser desorption [S, 91 
and electrospray ionization (ESI) [lo-121 processes 
have appeared as new technology for high-mass analy- 
sis by mass spectrometry. Mass spectrometry exhibits 
a variety of unique capabilities for a broad range of 
applications and is commonly used for solving bioana- 
lytical problems when high sensitivity and structural 
information are required [13]. The newly developed 
technique of ES/MS, which allows the formation of 
gas-phase macromolecular ions directly from solution 
at atmospheric pressure via ion evaporation 114, 151, 
represents an important advancement in mass spec- 
trometry technology that significantly extends the 
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range of mass spectrometry applications to the field of 
biomedical research [ 166201. 
Traditionally, mass spectrometry-based research in 
the field of noncovalent interaction between 
biomolecules has been considered difficult, if not im- 
possible, mainly owing to the incompatible experimen- 
tal requirements, The unique feature that sets ES1 apart 
from the rest of the available ionization techniques is 
that it utilizes highly charged liquid droplets as the ion 
evaporation medium, allowing the sample being ana- 
lyzed to remain in its solution form prior to mass 
spectrometry analysis [lo, 13, 151. The obvious advan- 
tage is that a protein sample can be introduced directly 
from solution in its biologically active form for mass 
spectrometry analysis. Ganem et al. [Zl, 221 reported 
the first application of ES/MS for noncovalent binding 
between FKBP (an immunosuppressive binding pro 
tein) and immunosuppressive agents (FK506 and ra- 
pamycin) and the enzyme-substrate interaction in 
which the enzymatic reaction of hen egg-white 
lysozyme with various substrates were studied. More 
recently, the observation of a ternary complex between 
the dimeric enzyme human immunodeficiency virus-l 
protease and a substrate-based inhibitor was also re- 
ported 1231. We have been studying the noncovalent 
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interaction of human rus protein with its guest ligands 
guanosine diphosphate (GDP) and guanosine triphos- 
phate (GTP), and the successful ES/MS detection of 
the ras-GDP noncovalent complex has recently been 
reported [24]. The experimental conditions have been 
further refined by the use of a biological buffer solu- 
tion to stabilize the noncovalent complexes of rus~GDP 
and ras-GTP in solution prior to mass spectrometry 
analysis [25]. 
An extension of this research is the feasibility study 
of using ES/MS for probing the noncovalent interac- 
tion between protein molecules. We used interferon 
(IFNl-y as the proteinprotein interaction model for 
this purpose. IFN-y is a protein that exerts virus-non- 
specific antiviral activity, at least in homologous cells, 
through cellular metabolic processes involving synthe- 
sis of both RNA and protein. IFN--y, also known as 
macrophage-activating factor, is commonly named 
“immune” or type-11 IFN. Its primary natural source is 
T cells. Both helper (CD4+) and cytotoxic (CDS’) T 
cells have the capacity to produce IFN-?, after activa- 
tion with anti-CD3 [26]. 
Despite the different biological properties of IFN-y, 
it is a lymphokine with potent immunomodulatory 
activities in addition to its antiviral role. IFN--r is 
unique among the interferons in activating macro- 
phages and in the induction of class II molecules of the 
major histocompatibility complex. The activation 
macrophages are important in the killing of intracellu- 
lar parasites and possibly tumor cells in vivo. The 
induction of class II molecules may facilitate antigen 
presentation to helper T cells, although inappropriate 
expression may be implicated in the development of 
autoimmune disease. 
Human IFN-7 is available in a pure form as a result 
of recombinant DNA technology and has been coded 
in both prokaryotes, such as Escherichia coli, and eu- 
karyotes, such as Chinese hamster ovary and yeast 
cells. Mature IFN-7 is a protein of 143 amino acids 
t u 17 kDa) with an excess of basic amino acid residues. 
The active form of this protein is a homodimer and is 
also known to be both heat and acid labile [27]. 
In this report, we describe the use of electrospray 
ionization for the detection of the biologically active 
IFN-y dimer. The effect of the ion sampling orifice 
potential (OR1 on the mass spectrometry detection of 
the noncovalent IFN-y dimer and its charge-state dis- 
tribution is also discussed. This study is further ex- 
tended to probe the proteinligand interaction of 
ras_GDP. 
Experimental 
Preparation of Human Interferon-y 
The IFN-7 used in these studies was recombinant 
human IFN-y D expressed in E. coli containing an 
initiator methionine at the N-terminus [theoretical av- 
erage molecular weight (MW) is 16,907.4 Da]. A 10-L 
scale fermentation was purified by a conventional pu- 
rification process similar to that described previously 
in detail for murine recombinant IFN-y [28]. The initial 
cell extract was treated with polyethylene imine for 
precipitation of subcellular particles and large frag- 
ments of nucleic acids, resulting in a clear supernatant. 
Further purification was obtained by binding to 
phenylSepharose, followed by elution with ethylene 
glycol. A cation-exchange chromatography step on car- 
boxymethyl-Sepharose was required for removal of 
proteolytic fragments as well as certain E. coli contam- 
inants. Following concentration by ultrafiltration, a gel 
filtration chromatography step using Sephadex G-100 
was performed to separate components on the basis of 
MW. Fractions were combined that corresponded to 
the noncovalent dimeric form weighing approximately 
32,000 Da. Subsequent analysis of the N-terminus con- 
firmed the presence of N-terminal methionine fol- 
lowed by the predicted sequence for human IFN-y. 
The resulting preparation was dialyzed against USP 
water and lyophilized to the free base and was utilized 
in all mass spectrometry studies. The resulting prepa- 
ration was also analyzed by the cytopathic effect inhi- 
bition assay utilizing encephalomyocarditis (EMC) 
virus and L929 cells, as previously described [29], with 
human recombinant IFN-e-1 as a standard. Titers for 
the latter were calibrated against a reference standard 
of natural human leukocyte IFN using EMC virus and 
human foreskin fibroblast cells (FS711. Protein concen- 
trations were determined according to Bradford [30] 
using bovine serum albumin as standard. The subse- 
quently derived specific bioactivity was consistent for 
a homogenous IFN-y preparation; 2 X lo6 IU/mg P. 
All chromatographic materials were obtained from 
Pharmacia Fine Chemical (Uppsala, Sweden). 
Preparation of Cytochrome c Solution 
Horse heart cytochrome c was purchased from Sigma 
Chemical Co. (St. Louis, MO) and was used without 
further purification. The stock solution of cytochrome c 
was prepared in solution of pH -9.3 (adjusted by 
30% NH,OH) to a final concentration of 4 X 10e4 M. 
A second cytochrome c solution was prepared by 
diluting the stock solution of cytochrome c with the 
same solvent (pH -9.3) to a final protein concentra- 
tion of approximately 70 PM. 
Preparation of H-m-GDP Complex 
C-terminally truncated normal human H-rus (l-166) 
was expressed in E. coli from a synthetic rus gene 
under the control of both the Ipp and laq promoters 
[31]. The noncovalently bound m-GDP complex 
was subsequently purified from fermentor-grown, 
isopropyl-P-o-thiogalactopyranoside-induced cells by 
the previously reported procedure [32]. The stock solu- 
tion (_ 20 Fg/pL) of m-GDP complex (FPLC iso- 
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lated sample) was kept in a solution containing 64 mM 
Tris HCI pH 7.6, 10 mM MgCl,, 1 mM NaN,, 0.5 mM 
dithioerythritol, and 250 mM NaCI. For mass spec- 
trometry analysis, the stock solution was further di- 
luted to a final concentration of approximately 2 
pg/pL. All sample solutions were stored at 4 “C prior 
to mass spectrometjr analysis. The activity of the rus 
protein in GDP binding assays and GTPase assays was 
comparable to previously published data [32-341. De- 
tails of the experimental conditions for stabilizing the 
noncovalent complexes have been described elsewhere 
[24, 251. 
Mass Spectrometry 
A Sciex API III triple quadrupole mass spectrometer 
equipped with a standard atmospheric pressure ion- 
ization source (Sciex, Inc., Thornhill, Ontario, Canada) 
was used to sample ions produced from the ES1 inter- 
face. In this system, ions were sampled into the vac- 
uum for mass analysis through a 125-pm i.d. orifice at 
the end of a cone extending toward the atmosphere. 
The atmosphere-to-vacuum transition occurs through 
this orifice without an intermediate differentially 
pumped region. The atmospheric side of the sampling 
cone was bathed with a curtain of high-purity dry 
nitrogen gas (- 0.7 L/min), which acted both as a 
barrier to restrict contaminants and solvent vapor from 
entering the mass spectrometer vacuum chamber and 
as an ion-molecule declustering region. High vacuum 
was maintained by cryogenically cooled surfaces main- 
tained at 15-20 K. 
The mass analysis was carried out by scanning 
either the first quadrupole (Ql) or the third quadrupole 
(Q3) from 800 to 2400 Da at a typical scan rate of 4 
s/scan. The sample, in its liquid form, was introduced 
either through direct infusion of solution or by flow 
injection via a Rheodyne external loop injector with a 
preselected solvent system. In the latter case, an Ap- 
plied Biosystems, Inc. (Foster City, CA) model 140A 
dual-syringe micro liquid chromatography pump was 
used to deliver a constant liquid flow of 5-100 
pL/min. 
Results and Discussion 
Interferon-y 
To our knowledge, there has been no report of any 
successful mass spectrometry detection of the dimeric 
form of IFN-y. Our earlier attempts to analyze the 
IFN-y dimer under typical ES1 conditions (i.e., 50% 
MeOH, 0.1% trifluoroacetic acid, pH N 2.5) resulted in 
an observed mass spectrum with a well-defined “bell- 
shaped” multiply charged ion distribution (from + 8 to 
+ 22 charges, data not shown) whose MW (16,910 Da) 
corresponded to the monomeric IFN-y. In principle, 
the multiple charging phenomenon that occurs with 
ES1 can have a strong denaturing effect through simple 
charge repulsion that destroys the higher order interac- 
tions, which are essential for protein-protein associa- 
tion; however, we have observed that with special 
sample handling, the specific protein-protein noncova- 
lent dimer can be preserved in the gas phase. 
Experience gained from our earlier study of 
rus-GDP and ras-GTP noncovalent complexes 124, 251 
prompted us to further examine the IFN-7 dimer with 
aqueous solution (i.e., no organic cosolvent added) at 
different pH conditions. Figure 1 shows the mass spec- 
trum of the IFN-y dimer in distilled water with a 
measured pH of approximately 6.7. The mass spec- 
trum reveals that the IFN-y dimer was dissociated on 
mass spectrometry analysis at a solution pH of 6.7. 
Because isoelectric focusing indicated that the protein 
has a p1 value of higher than 9, a fresh protein solution 
was prepared, and its mass spectrum subsequently 
recorded in aqueous solution adjusted to a pH -9 
with 30% NH,OH. Interestingly, the dimeric form of 
IFN-y (observed MW 33,819 Da) was preserved and 
successfully detected by mass spectrometry under 
these conditions (Figure 2a). 
The MW determination of protein complexes com- 
posed of identical subunits (i.e., homodimer in contrast 
to heterodimer) requires special attention. Het- 
erodimers can be readily distinguished from their 
monomeric components by the different multiply 
charged ion distributions that give rise to two different 
average MWs; however, the ion distribution and ob- 
served mass-to-charge ratio values for the monomeric 
form of a homodimer will overlap with the even charge 
states of its dimeric counterpart. The key to determins 
ing the presence of a protein homodimer is the detec- 
tion of signals corresponding to its multiply prot+ 
nated odd charge states [35]. Careful examination of 
ions observed in Figure 2a reveals that these ions 
correspond to the various multiply charged states of 
Figure 1. Full-scan (800-2400 Da in 4 s) ES mass spectrum of 
the IFIGy diner noncovalent complex obtained from aqueous 
solution (pH * 6.7). The spectrum shows a multiply charged ion 
distribution ranging from +8 to +22 charges. The observed 
molecular weight (MW) 16,910 Da (inset), which corresponds to 
the IFN-y monomer. No IFN-y dimer was detected under these 
conditions. 
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Figure 2. Full-scan (800-2400 Da in 4 s) ES mass spectrum of 
the IFN-7 dimer noncovalent complex obtained from aqueous 
solution (pH -9). (a) at OR = 50 V, the IFN-y dimer was de- 
tected by the observation of the corresponding multiply charged 
ions with charge states of +15 to f30. (b) at OR = 70 V, the 
IFN-7 dimer signals have decreased dramatically. (c) At OR = 
100 V, the IFN-y dimer has almost disappeared from the spec- 
trum. For easy comparison, the odd charge states are denoted by 
an asterisk. 
the dimeric 1FN-y. The observed values of m / z 2256, 
2115, 1990, 1880, 1781, 1692, 1611, 1538, 1471, 1410, 
1354, 1302, 1254, 1209, 1167, and 1128 are assigned as 
the charge states of + 15 to +30, respectively. For easy 
comparison, the odd charged ions in Figure Za-c are 
denoted by an asterisk. 
It has been shown, with horse heart cytochrome c, 
that random protein aggregation can occur because of 
high protein concentration [36]. To rule out the poten- 
tial of forming a protein dimer via the concentration 
effect, the mass spectrometry detection of the IFN-y 
dimer was further investigated. First, horse heart cy- 
tochrome c was analyzed at high concentration (4 X 
10m4 M) by ES/MS. The solvent and mass spectrome- 
try operation parameters were the same as those used 
to obtain the spectrum in Figure 2a. The observed 
signals (Figure 3a) at m / z 2061, 1766, 1546, and 1374 
correspond to the +6, -t-7, +8, and + 9 charge states, 
respectively, of monomeric cytochrome c. In addition, 
signals corresponding to the odd charges (fll and 
+13) of the cytochrome c dimer were also detected at 
m /z 2248 and 1902, respectively. When the protein 
concentration was diluted to approximately 70 PM, no 
signals corresponding to the odd charges of the cy- 
tochrome c dimer were detected (Figure 3b). Next, an 
equal molar mixture of IFN-y dimer and cytochrome c 
(each at a final concentration of 35 PM) was prepared, 
and the mass spectrum was recorded (Figure 3~). In 
Figure 3. Full-scan (1200-2400 Da in 4 s) ES mass spectrum of 
(a) horse heart cytochrome c obtained from aqueous solution (pH 
-9.3). At OR = 50 V, the cytochrome c dimer resulting from 
high protein concentration (4 x 10m4 M) was detected by the 
observation of the corresponding +ll and +13 multiply charged 
ions at m/z 2248 and 1902, respechvely, numbers in parentheses 
correspond to the different charge states of the monomeric cy- 
tochrome c. (b) ES mass spectrum of horse heart cytochrome c 
obtained from diluted aqueous solution (pH -9.3) with a final 
concenkation of approximately 70 PM. (c) ES mass spectrum 
obtained from an equal molar mixture (final concentration of 
approximately 35 PM each) of IFN-y dimer and horse heart 
cytochrome c (pH - 9.3). The IFN-y dimer signals are denoted 
by an asterisk; signals corresponding to cytochrome c are indi- 
cated by an arrow. 
addition to the IFN-7 dimer, signals corresponding to 
the + 6, + 7, + 8, and + 9 charge states of cytochrome c 
(nt /Z 2016, 1766, 1546, and 1374, respectively) were 
detected. As expected, no signals of the cytochrome c 
dimer were observed. Furthermore, signals corre- 
sponding to the random attachment between IFN-y 
and cytochrome c were also absent. This result further 
confirmed that the IFN-y dimer detected by mass 
spectrometry under these experimental conditions was 
the specific noncovalent IFN-y dimer and was not the 
result of the random dimerization due to the concen- 
tration effect. 
Our observation of forming the multiply charged 
positive ions in ES1 with the protein sample prepared 
in alkaline solution (pH - 9) is consistent with other 
studies [37] in which myoglobin, lysozyme, and lactal- 
bumin were used as protein standards. On the basis of 
their observations, these investigators suggested that 
ionization processes other than the simple evaporation 
of preformed solution ions are involved in ESI. More 
important, our finding indicates that the protein non- 
covalent dimer can survive the electrostatic repulsions 
exerted by the multiply charged ions generated by ESI. 
Following the successful detection of the noncova- 
lent complex of the IFN-y dimer, the energy required 
to break apart this protein-protein interaction was 
next investigated. Mass spectra were recorded of the 
IFN-y dimer solution (pH -9) at different OR set- 
tings from 40 to 200 V (see Figure 2a-c for the resul- 
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tant mass spectra at low, medium, and high OR volt- 
ages). The percentage of the dimeric form was calcu- 
lated from the change in ion intensity corresponding to 
the odd charge states of the IFN-y dimer. This ratio of 
ion intensity was then normalized against the value 
obtained at OR = 50 V. (Note: We did not detect any 
protein-related sibma at OR 2 40 V.) The percentage of 
IFN-7 in the dimer form thus obtained is not an 
absolute value; rather, it should be treated as a relative 
measurement of preservation of the protein dimer on 
change in the OR setting. Figure 4 shows the percent- 
age of the IFN-y dimer observed in the experimental 
OR setting. Unlike the m-GDP noncovalent complex 
system discussed later, dissociation of the IFN-7 non- 
covalent dimer was triggered by an OR setting as low 
as 60 V. The decrease in the dimer present in the 
spectrum was found to be a linear function of the 
OR setting. At OR = 130 V, virtually no IFN-7 was 
present as a dimer. These results imply that dissocia- 
tion of the gas-phase IFN-y dimer requires very little 
energy. Because both IFN-y subunits have the same 
number of protonation sites, the charges resulting from 
ES1 should be distributed equally on the dimer 
molecule. Therefore, the electrostatic repulsion forces 
within the gas-phase noncovalent dimer of the highly 
charged IFN--y subunits may facilitate dimer dissocia- 
tion at low OR settings. This also has the implication 
that at OR = 50 V (i.e., the lowest orifice potential WC 
used), the gas-phase IFN-7 dimer might already be 
partially dissociated, making the use of this mass spec- 
trometry methodology in determining solution-phase 
noncovalent association/dissociation constants more 
difficult. 
ras-GDP Nuncovalent Complex 
ras Protein is a G-protein involved in the regulation of 
cell growth and differentiation. It is known that when 
Figure 4. Effect of OR on the gas-phase IFN-r dimer noncova- 
lent complex, showing the percentage of the IFWy dimer de- 
tected by mass spechometry from protein solution (pH - 9) at 
different orifice voltages. At OR =133 V, virtually no IFN-y 
dimer was present. 
YUS is bound to GTP, it becomes biologically active, 
initiating cell growth and differentiation, and when 
bound to GDP, it is inactive [38-401. Mutant ras pro- 
teins deficient in the ability to change from GTP- to 
GDP-bound states have been implicated in uncon- 
trolled cell growth. Therefore, the ability to differenti- 
ate GDP-bound rus from GTP-bound ras is of impor- 
tance in the study of uncontrolled cell growth. The 
noncovalent complex of ras~GDP has been detected by 
ES/MS with a recorded MW of 19,295 Da [241. The 
noncovalent rus-GTP complex was also detected by 
ES/MS with the observed MW of 19,375 Da, and 
details of this work have been reported elsewhere 1251. 
The best condition for achieving optimum mass spec- 
trometry sensitivity and signal stability for these com- 
plexes was found at a solution of pH - 4 without any 
organic cosolvent added. 
As discussed earlier, dissociation of the gas-phase 
noncovalent IFN-r dimer can be induced by simply 
increasing the OR setting. The same experiment can 
also be applied to study the GDP ligand-binding 
affinity with its host rus protein. Therefore, the effect 
of this collisional excitation in the declustering region 
on the observation of the ms-GDP noncovalent com- 
plex was investigated. To achieve this, the mass spec- 
trum of m-GDP was recorded from a sample solution 
of pH - 4 while the OR voltage was varied from 40 to 
as high as 200 V. The resultant mass spectra at low (40 
V), medium (120 V), and high (200 V) OR settings are 
shown in Figure 5a-c. At OR = 40 V, the mass spec- 
trum revealed only signals of the ras-GDP complex; 
no signals corresponding to the apo-ras protein were 
detected, indicating no dissociation of the rus-GDP 
noncovalent complex. Surprisingly, the noncovalent 
complex of m-GDP was observed as one of the major 
components, even at the OR setting of 200 V. This 
could be the result of electrostatic attraction between 
the oppositely charged GDP and MS protein molecules, 
causing the complex to appear more stable than ex- 
pected. The multiply charged ion distribution was 
centered at the + 11 charge state for OR = 40 V and 
was found to be the same for OR as high as 120 V. The 
center of this charge distribution shifted to the +lO 
charge state when OR was increased to 140 V. Further 
increase in the voltage (160,180, and 200 V) resulted in 
a shift of the charge-state center to the + 9 charge state. 
The change in the observed multiple charge distribu- 
tion pattern at different OR settings (40-200 V) is 
considered minor. 
Although the charge distribution changed very little 
(from +11 to +Y charges) with respect to OR, the 
relative amount of the m-GDP signals was highly 
affected by the different OR settings (Figure 6). At 
OR = 200 V, three major components were observed 
with determined average MWs of 19,295, 18,930, and 
18,852 Da, respectively. The MWs of 19,295 and 18,852 
represent the rus-GDP complex and the unbound apo- 
rus protein, respectively, whereas the origin of the 
other l&930-Da component is not understood at the 
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Figure 5. Full-scan (800-2400 Da in 4 s) ES mass spectra of the 
m-GDP noncovalent complex obtained from aqueous solution 
with the pH adjusted to approximately 4.0. The spectra were 
measured at different OR settings: (a) OR = 40 V, (b) 120, and Cc) 
200 V. The corresponding deconvoluted spectra arc presented in 
the inwts (see text for discussion). 
Figure 6. Effect of OR on the gas-phase ras_GDP noncovalent 
complex, showing the relative percentage of the three major 
components detected by mass spectrometry from a protein solu- 
tion (pH -4) at different orifice voltages. 
present time. Figure 6 shows the relative amount of 
these three components versus the experimental OR 
setting. Evidently, the ras-GDP signal did not de- 
crease until OR = SO V. At OR = 200 V, the intact 
noncovalent complex of rus-GDP was still detected, 
and its ion intensity accounted for approximately 48% 
of the total protein signals. It was expected that the 
remaining protein would be detected as the dissoci- 
ated apo-ras protein; however, to our surprise the 
apo-ras protein signal represented only 19%, and the 
remaining 33% was accounted for by the l&930-Da 
component. 
Careful consideration of all of the possible adducts 
observed in the ES mass spectrum revealed no mean- 
ingful information with regard to the identity of the 
l&930-Da component. The energy required to generate 
l&930-Da component from the complex was less than 
that required for stripping off the GDP from the pro- 
tein complex in the gas phase, as indicated in Figure 6. 
The free form of the ras protein signal was not ob- 
served until OR reached approximately 155 V, whereas 
the sihmal corresponding to the l&930-Da component 
increased linearly with OR as soon as OR was higher 
than SO V. The release of GDP under these conditions 
is considered not to be a result of the protein denatura- 
tion in solution, as commonly observed for both acid- 
and organic solvent-induced protein denaturation [24, 
251. On the contrary, GDP was most likely knocked out 
from its binding pocket by means of a collision be- 
tween the gas-phase ras-GDP complex and the N, 
curtain gas. The implication of using this OR voltage 
breakdown curve as an indication of association/dis- 
sociation measurement is very promising, even though 
its true correlation to the solution-phase noncovalent 
interaction requires further investigation, 
Conclusions 
We have successfully applied ES/MS to the detection 
of the noncovalent interaction of IFN-y dimer. The 
ability to use alkaline solution (pH -9) is critical to 
this application. These results indicate that a 
protein-protein noncovalent complex can be desorbed, 
at or very close to its native solution conformation, as 
multiply charged ions and maintained in the gas phase. 
Dissociation of the gas-phase noncovalent com- 
plexes can be induced by increasing the OR voltage. In 
the two noncovalent complexes studied, the gas-phase 
rus-GDP complex required a substantial amount of 
energy to initiate the dissociation process, whereas the 
IFN-y dimer started to dissociate immediately follow- 
ing the OR increase. The higher order conformation of 
the ras protein could still be preserved (or partially 
preserved) in the gas phase so that GDP is well pro- 
tected in its binding pocket; hence more energy is 
required to dissociate the gas-phase rus-GDP complex. 
In contrast, the IFN-y dimer is composed of two iden- 
tical protein subunits that are equally charged on ESI. 
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Electrostatic repulsion between the charged subunits 14. Bruins, A. I’.; Covey, T. R.; Henion, J. D. Anal. Chem. 1987, 
contributes to an inherently less stable noncovalent 
complex that is dissociated at a lower OR setting. In 
addition, the large cross section of the IFN-y dimer 
increases the probability of effective collisions with gas 
molecules. It has been suggested [23] that covalent and 
noncovalent complexes observed under ES1 can be 
easily differentiated by raising the OR. Our study of 
the gas-phase noncovalent complexes of uas-GDP and 
the IFN-7 dimer, however, underscores the impor- 
tance of careful use of this technique. The ES/MS 
technique could be extended further to study the com- 
plexes between proteins and other compounds of phar- 
maceutical interest. The extension of this research in 
probing the various kinetics of enzyme-substrate in- 
teractions is the subject of current research in our 
laboratory. 
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